16,713 Shares in Centene Corporation $CNC Acquired by First Heartland Consultants Inc.

First Heartland Consultants Inc. acquired a new stake in Centene Corporation (NYSE:CNC) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 16,713 shares of the company’s stock, valued at approximately $688,000.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Norges Bank purchased a new stake in shares of Centene during the second quarter valued at $1,435,997,000. State Street Corp grew its holdings in shares of Centene by 2.3% in the second quarter. State Street Corp now owns 23,186,927 shares of the company’s stock worth $1,258,586,000 after purchasing an additional 514,600 shares during the last quarter. AQR Capital Management LLC increased its stake in Centene by 76.6% in the 3rd quarter. AQR Capital Management LLC now owns 14,654,834 shares of the company’s stock worth $522,885,000 after buying an additional 6,356,152 shares during the period. Invesco Ltd. lifted its holdings in Centene by 5.7% during the 2nd quarter. Invesco Ltd. now owns 11,725,910 shares of the company’s stock valued at $636,482,000 after buying an additional 633,946 shares in the last quarter. Finally, Deerfield Management Company L.P. boosted its position in Centene by 184.0% in the 3rd quarter. Deerfield Management Company L.P. now owns 9,046,000 shares of the company’s stock valued at $322,761,000 after buying an additional 5,860,630 shares during the period. 93.63% of the stock is currently owned by institutional investors.

Centene Stock Up 0.4%

Shares of NYSE CNC opened at $32.94 on Wednesday. The stock has a market capitalization of $16.20 billion, a PE ratio of -2.42, a price-to-earnings-growth ratio of 0.73 and a beta of 0.48. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.87. Centene Corporation has a 12-month low of $25.08 and a 12-month high of $66.03. The stock’s fifty day simple moving average is $41.21 and its two-hundred day simple moving average is $38.73.

Centene (NYSE:CNC) last issued its quarterly earnings data on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The firm had revenue of $49.73 billion during the quarter, compared to analysts’ expectations of $48.41 billion. During the same period in the prior year, the business posted $0.80 EPS. The firm’s quarterly revenue was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, analysts expect that Centene Corporation will post 6.86 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on CNC shares. Morgan Stanley raised their target price on shares of Centene from $38.00 to $45.00 and gave the stock an “equal weight” rating in a research report on Wednesday, March 4th. Wells Fargo & Company set a $44.00 price objective on Centene and gave the stock an “equal weight” rating in a research note on Wednesday, February 18th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $41.00 target price on shares of Centene in a research report on Monday, February 9th. Wall Street Zen cut Centene from a “buy” rating to a “hold” rating in a report on Sunday, February 15th. Finally, Mizuho set a $41.00 price target on Centene and gave the company a “neutral” rating in a research note on Tuesday, March 10th. Three research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $41.81.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.